Cubist Systematic Strategies LLC Sells 22,100 Shares of MaxLinear, Inc. (NASDAQ:MXL)

Cubist Systematic Strategies LLC reduced its stake in shares of MaxLinear, Inc. (NASDAQ:MXL - Free Report) by 16.7% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 110,249 shares of the semiconductor company's stock after selling 22,100 shares during the period. Cubist Systematic Strategies LLC owned approximately 0.13% of MaxLinear worth $2,181,000 at the end of the most recent reporting period.

Several other institutional investors also recently made changes to their positions in MXL. Assenagon Asset Management S.A. raised its stake in MaxLinear by 339.9% in the 4th quarter. Assenagon Asset Management S.A. now owns 1,250,769 shares of the semiconductor company's stock valued at $24,740,000 after purchasing an additional 966,468 shares during the last quarter. JPMorgan Chase & Co. increased its stake in shares of MaxLinear by 44.6% during the 3rd quarter. JPMorgan Chase & Co. now owns 935,739 shares of the semiconductor company's stock valued at $13,550,000 after acquiring an additional 288,607 shares during the last quarter. Barclays PLC increased its stake in shares of MaxLinear by 47.6% during the 3rd quarter. Barclays PLC now owns 335,804 shares of the semiconductor company's stock valued at $4,860,000 after acquiring an additional 108,346 shares during the last quarter. Vaughan Nelson Investment Management L.P. increased its stake in shares of MaxLinear by 10.0% during the 4th quarter. Vaughan Nelson Investment Management L.P. now owns 1,268,857 shares of the semiconductor company's stock valued at $25,098,000 after acquiring an additional 115,867 shares during the last quarter. Finally, GAMMA Investing LLC increased its stake in shares of MaxLinear by 19.1% during the 4th quarter. GAMMA Investing LLC now owns 4,134 shares of the semiconductor company's stock valued at $82,000 after acquiring an additional 662 shares during the last quarter. 90.79% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In related news, Director Ted L. Tewksbury III sold 6,071 shares of the stock in a transaction on Friday, May 2nd. The stock was sold at an average price of $10.40, for a total value of $63,138.40. Following the completion of the transaction, the director now owns 74,995 shares in the company, valued at $779,948. This trade represents a 7.49% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Corporate insiders own 7.80% of the company's stock.

MaxLinear Stock Down 0.8%

Shares of MaxLinear stock traded down $0.10 on Thursday, hitting $12.69. 761,034 shares of the company's stock traded hands, compared to its average volume of 1,431,447. The stock has a market cap of $1.07 billion, a P/E ratio of -4.33 and a beta of 1.66. The company has a quick ratio of 1.28, a current ratio of 1.77 and a debt-to-equity ratio of 0.24. The firm's 50-day moving average is $11.17 and its 200 day moving average is $15.45. MaxLinear, Inc. has a 52-week low of $8.35 and a 52-week high of $26.59.

MaxLinear (NASDAQ:MXL - Get Free Report) last posted its quarterly earnings results on Wednesday, April 23rd. The semiconductor company reported ($0.05) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.05). MaxLinear had a negative return on equity of 21.94% and a negative net margin of 68.01%. The business had revenue of $95.93 million for the quarter, compared to analyst estimates of $95.32 million. During the same period in the prior year, the company posted ($0.21) EPS. The business's revenue was up .7% compared to the same quarter last year. Equities analysts anticipate that MaxLinear, Inc. will post -0.37 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on MXL shares. Stifel Nicolaus dropped their price objective on shares of MaxLinear from $26.00 to $16.00 and set a "buy" rating for the company in a research note on Thursday, April 17th. Roth Capital set a $11.00 target price on MaxLinear and gave the stock a "neutral" rating in a report on Thursday, April 24th. Wells Fargo & Company boosted their target price on MaxLinear from $19.00 to $20.00 and gave the stock an "equal weight" rating in a report on Thursday, January 30th. Needham & Company LLC reiterated a "hold" rating on shares of MaxLinear in a report on Thursday, January 30th. Finally, Susquehanna decreased their target price on MaxLinear from $25.00 to $23.00 and set a "neutral" rating for the company in a report on Thursday, January 30th. Five analysts have rated the stock with a hold rating and four have given a buy rating to the company's stock. According to MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus price target of $19.06.

About MaxLinear

MaxLinear, Inc provides communications systems-on-chip solutions worldwide. Its products integrate various portions of a high-speed communication system, including radio frequency, high-performance analog, mixed-signal, digital signal processing, security engines, data compression and networking layers, and power management.